Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065-Reference-Cited by-同舟云学术

Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065

Published:1994-05 Issue:1 Volume:112 Page:207-213
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Warner Timothy D.,Allcock Graham H.,Vane John R.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1994.tb13053.x/fullpdf

Reference32 articles.

1. The endothelin receptor antagonists BQ-123 and PD 145065 reverse established vasoconstrictor responses to endothelin-1 in vitro;ALLCOCK;Br. J. Pharmacol.,1993

2. The endothelin receptor antagonists BQ-123 and PD 145065 reverse established pressor responses to endothelin-1 in the anaesthetised rat;ALLCOCK;Br. J. Pharmacol.,1994

3. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat;ÄNGGÅRD;J. Cardiovasc. Pharmacol.,1989

4. Cloning and expression of a cDNA encoding an endothelin receptor;ARAI;Nature,1990

5. Pharmacologic characterization of an endothelinA (ETA) receptor antagonist in conscious rats;BAZIL;J. Cardiovasc. Pharmacol.,1992

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine;EPMA Journal;2021-08-04

2. Endothelin and the heart in health and diseases;Peptides;2019-01

3. PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?;Trends in Pharmacological Sciences;2018-08

4. New Drugs and Emerging Therapeutic Targets in the Endothelin Signaling Pathway and Prospects for Personalized Precision Medicine;Physiological Research;2018-05-06

5. Endothelin;Pharmacological Reviews;2016-03-08